Since then, many studies have reported the benefits of MRA therapy in patients with CKD for both renal [6,168] and CKD-associated comorbidities such as vascular calcification [169], insulin resistance [170], left ventricular mass and function, blood pressure, and vascular stiffness [171]. Here, INS is linked to chronic kidney disease.